Double‐Dose Versus Standard‐Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention

BACKGROUND: Prior Studies have suggested better outcomes in smokers compared with nonsmokers receiving clopidogrel (“smoker's paradox”). The impact of a more intensive clopidogrel regimen on ischemic and bleeding risks in smokers with acute coronary syndromes requiring percutaneous coronary int...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Am Heart Assoc
Autori principali: Bossard, Matthias, Granger, Christopher B., Tanguay, Jean‐Francois, Montalescot, Gilles, Faxon, David P., Jolly, Sanjit S., Widimsky, Petr, Niemela, Kari, Steg, Philippe Gabriel, Natarajan, Madhu K., Gao, Peggy, Fox, Keith A. A., Yusuf, Salim, Mehta, Shamir R.
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2017
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5721756/
https://ncbi.nlm.nih.gov/pubmed/29101117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.117.006577
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi